-+ 0.00%
-+ 0.00%
-+ 0.00%

Oppenheimer Initiates Coverage On Precision BioSciences with Outperform Rating, Announces Price Target of $20

Benzinga·06/09/2026 11:32:54
Listen to the news
Oppenheimer analyst Joseph Thome initiates coverage on Precision BioSciences (NASDAQ:DTIL) with a Outperform rating and announces Price Target of $20.